Trials / Completed
CompletedNCT05403398
BSCU1 and Immune Function
Change in Markers of Immune Function Associated With Bacillus Subtilis CU1 Intervention in Different Age Groups
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 89 (actual)
- Sponsor
- Lesaffre International · Industry
- Sex
- All
- Age
- 3 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
The current study aims to explore a range of possible pathways by which BSCU1 could beneficially modulate the immune system, in three target populations representing the general population.
Detailed description
This exploratory study is designed as a single-arm study with repeated measures, involving three different populations, in which each subject serves as its own control. The duration of the intervention is 4 weeks, with biomarker assessments at baseline, after 2 weeks, and after 4 weeks intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | B. subtilis CU1 | 2 billion CFUs daily, for 4 weeks |
Timeline
- Start date
- 2022-06-07
- Primary completion
- 2022-10-18
- Completion
- 2023-03-20
- First posted
- 2022-06-03
- Last updated
- 2024-01-08
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05403398. Inclusion in this directory is not an endorsement.